doi:10.1016/0278-6915(87)90143-8.[Crossref], [PubMed], [Web of Science ] , [Google Scholar])
While Adderall is not approved for this purpose, weight loss can be a common side effect due to its effects on appetite
For most patients starting GLP-1 treatment for weight management, semaglutide (either Wegovy or compounded) is a common first choice because it has the longest track record, the most clinical data, and the widest availability
Contents: 5 mg lyophilized (freeze-dried) powder provided in a 3 ml vial, sealed and sterile
The results from clinical trials on Mounjaro (tirzepatide) for weight loss have been impressive
More than 80% consider the price of prescription drugs unreasonable, and most support increased regulation to lower costs